Advertisement
Advertisement

BSEM

B

BioStem Technologies, Inc. Common Stock

4.09
USD
Sponsored
0.00
0.00%
Aug 07, 11:07 UTC -4
Closed
exchange

Pre-Market

4.01

-0.08
-1.90%

BioStem Technologies, Inc. Common Stock Profile

About

BioStem Technologies Inc. is a regenerative medicine company. It focused on the development, manufacture and commercialization of placental derived biologics. The company's portfolio of brands includes VENDAJE(R), VENDAJE AC(R) and VENDAJE OPTIC(R). BioStem Technologies Inc. is based in POMPANO BEACH, FLORIDA.

Info & Links

CEO

Headquarters

--

Sector

Medical

Website

--

Auditor

Share holders

--

Employees

--

BioStem Technologies, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

68.19M

Enterprise Value

68.19M

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.96

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

-10.82%

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

-1.11

Share Statistics

Beta (5Y Monthly)

0.11

52-Week Change

--

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

0.00

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement